Stakeholder Advisory Group

The Stakeholder Advisory Group (SAG) is mainly comprised of non-commercial industry stakeholders and consumer representatives. As a sub-committee supporting the Inter-Governmental Policy Reform Group (IGPRG) it focuses on seeking views, perspectives and input from external and industry stakeholders.

Role

The Stakeholder Advisory Group (SAG) provides advice to IGPRG on national health reform initiatives including the National One Stop Shop, specifically in relation to: 

  • sector and industry perspectives as requested
  • sector and industry issues as relevant. 

The SAG considers future reform initiatives to improve health outcomes for all Australians.

Members

RepresentativeOrganisation
Professor Walter Abhayaratna (Chair)IGPRG member 
June ChallenAdvanced Pharmacy Australia
Professor Andrew DavidsonAssociation of Australian Medical Research Institutes
Professor Christopher Reid Australian Clinical Trials Alliance
Kelly BeerAustralian College of Nursing
Dr Karen Luxford Australian Council on Healthcare Standards
Carol HodgsonAustralian Health Research Alliance
Professor Richard Gray Australian Nursing and Midwifery Clinical Trials Network
Associate Professor Micah Peters  Australian Nursing and Midwifery Federation
Nicola WareAustralian Private Hospitals Association
Dr Katharine BassettCatholic Health Australia
John Stubbs AM Consumer Advocate 
Anne McKenzie AMConsumer Advocate 
Professor David Story Council of Presidents of Medical Colleges
Mary Ann Baquero GeronimoFederation of Ethnic Communities’ Council of Australia
Melissa WilliamsGlobal-Mark 
Fiona Loughlan Institute for Healthy Communities Australia
Susanne TegenNational Rural Health Alliance
Dr Talia AvrahamzonResearch Australia
Dr Mya CubittRoyal Australasian College of Medical Administrators 
Dr Kylie VuongRoyal Australian College of General Practitioners 
Linda BrownSafer Care Victoria
Luke SheehyUniversities Australia

 

Meetings

SAG aims to meet four times a year. Additional meetings may be held if needed.

  1. Stakeholder Advisory Group Meeting 01 – Communique
  2. Stakeholder Advisory Group Meeting 02 – Communique

Related committees or groups

Contact

Contact us for more information about IGPRG and sub-committees.

Date last updated:
Tags:
  • About clinical trials